Rare T-Cell Lymphomas Overview | LRF Ed Forum Series
1.6 هزار بار بازدید -
3 سال پیش
-
Steven M. Horwitz, MD of
Steven M. Horwitz, MD of Memorial Sloan Kettering Cancer Center discusses the diagnosis and treatment of rare T-cell lymphomas.
T-cell lymphomas account for about seven percent of all NHLs in the United States according to the Surveillance, Epidemiology, and End Results program. Each particular subtype of T-cell lymphoma is very uncommon. They can be aggressive (fast-growing) or indolent (slow-growing).
To learn more about T-cell lymphoma, visit lymphoma.org/tcell.
**This is an archived video from the Lymphoma Research Foundation's 2021 virtual North American Educational Forum on Lymphoma (Ed Forum). The Ed Forum is the most comprehensive lymphoma-specific educational conference in North America. This 2-½ day annual program provides critical information on treatment options, patient support issues, clinical trials, and the latest advances in lymphoma research to people with lymphoma and their loved ones. Learn more at lymphoma.org/edforum.
T-cell lymphomas account for about seven percent of all NHLs in the United States according to the Surveillance, Epidemiology, and End Results program. Each particular subtype of T-cell lymphoma is very uncommon. They can be aggressive (fast-growing) or indolent (slow-growing).
To learn more about T-cell lymphoma, visit lymphoma.org/tcell.
**This is an archived video from the Lymphoma Research Foundation's 2021 virtual North American Educational Forum on Lymphoma (Ed Forum). The Ed Forum is the most comprehensive lymphoma-specific educational conference in North America. This 2-½ day annual program provides critical information on treatment options, patient support issues, clinical trials, and the latest advances in lymphoma research to people with lymphoma and their loved ones. Learn more at lymphoma.org/edforum.
3 سال پیش
در تاریخ 1400/09/30 منتشر شده
است.
1,647
بـار بازدید شده